Structure of Nafamostat mesylate CAS 82956 11 4 - Nafamostat mesylate CAS 82956-11-4

Iden­ti­fi­ca­tion

CAS Number

82956-11-4

Name

Nafamo­stat mesylate

Syn­onyms

1D2T74921W
4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethane­sul­fonate
6-Car­bamim­i­­doyl-2-naph­thyl 4-car­bamim­i­­dami­­doben­­zoate methane­sul­fonate (1:2) [ACD/IUPAC Name]
6-car­bamim­i­­doyl­­naph­thalen-2-yl 4-car­bamim­i­­dami­­doben­­zoate methane­sul­fonate (1:2)
82956-11-4 [RN]
Acide méthane­sul­fonique – 4-car­bamim­i­­dami­­doben­­zoate de 6-car­bamim­i­­doyl-2-naphtyle (2:1) [French] [ACD/IUPAC Name]
Ben­zoic acid, 4-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester, methane­sul­fonate (1:2) [ACD/​Index Name]
DG2736000
Methansul­fon­säure –6-car­bamim­i­­doyl-2-naph­thyl-4-car­bamim­i­­dami­­doben­­zoat (2:1) [Ger­man] [ACD/IUPAC Name]
MFCD00941430 [MDL num­ber]
Nafamo­stat mesy­late [USAN]
(6-car­bamim­i­­doyl­­naph­thalen-2-yl) 4-(diaminomethylideneamino)benzoate;methanesulfonic acid
[6-[4-[[amino(azaniumyl)methylidene]amino]benzoyl]oxynaphthalene-2-carboximidoyl]azanium and methane­sul­fonate
[82956-11-4]
4-[(aminoiminomethyl)amino]-6-(aminoiminomethyl)-2-naphthalenyl ester-ben­­zoic acid, dimethane­sul­fonate
6-[amino(imino)methyl]-2-naphthyl 4-{[amino(imino)methyl]amino}benzoate dimethane­sul­fonate
6-amidi­no-2-naph­thyl 4-(amidinoamino)benzoate, methane­sul­fon­ic acid, methane­sul­fon­ic acid
6-Amidi­no-2-naph­thyl 4-guani­di­noben­­zoate dimethane­sul­fonate
6-Amidi­no-2-naph­thyl p-guani­di­noben­­zoate, dimethane­sul­fonate
6-car­bamim­i­­doyl-2-naph­thyl 4-car­bamim­i­­dami­­doben­­zoate methanesulfonate(1:2)
6-CAR­BAMIM­I­­DOYL­­NAPH­THALEN-2-YL 4-CAR­BAMIM­I­­DAMI­­DOBEN­­ZOATE ; BIS(METHANE­SUL­FON­IC ACID)
6-car­bamim­i­­doyl­­naph­thalen-2-yl 4-guani­di­noben­­zoate dimethane­sul­fonate
AMINO({[4-({[6-(AMMO­NIOMETHA­NIMI­DOYL)NAPH­THALEN-2-YL]OXY}CAR­BONYL)PHENYL]IMI­NO})METHANAMINI­UM DIME­SY­LATE
BEN­ZOIC ACID, 4-((AMINOIMI­NOMETHYL)AMINO)-, 6-(AMINOIMI­NOMETHYL)-2-NAPH­THALENYL
Ben­zoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dimethane­sul­fonate
ben­zoic acid, 4-[(aminoiminomethyl)amino], 6-(aminoiminomethyl)-2-naphthalenyl ester, methane­sul­fonate (1:2)
Coahibitor
Coahibitor ;FUT-175;Futhan
Futhan
Futhan, FUT-175
Nafamo­stat (mesy­late)
Nafamo­stat dimethane­sul­fonate
Nafamo­stat Mesi­late
Nafamo­stat Mesy­late(FUT-175)
Nafamo­stat Mesy­late,FUT-175,Futhan
nafamostatmesy­late
nafam­stat mesi­late
QA-7529
Rona­s­tat [Trade name]
UNII :1D2T74921W
UNII-1D2T74921W

SMILES

CS(=O)(=O)O.CS(=O)(=O)O.c1cc(ccc1C(=O)Oc2ccc3cc(ccc3c2)C(=N)N)NC(=N)N

Std­InChI

InChI=1S/C19H17N5O2.2CH4O3S/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23;21-5(2,3)4/h1-10H,(H3,20,21)(H4,22,23,24);21H3,(H,2,3,4)

Std­InChIKey

SRXK­IZXIRHMPFW-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C21H25N5O8S2

Mol­e­c­u­lar Weight

539.582

MDL Number

MFCD00941430

Prop­er­ties

Appear­ance

White pow­der

Melt­ing Point

259-261°C

Safe­ty Data

Sym­bol

health hazard jpg - Nafamostat mesylate CAS 82956-11-4GHS08

Sig­nal Word

Warn­ing

Haz­ard statements

H361fd

Pre­cau­tion­ary Statements

P281

Per­son­al Pro­tec­tive Equipment

Eye­shields, Gloves, type N95 (US), type P1 (EN143) res­pi­ra­tor filter

RIDADR 

NONH for all modes of transport 

WGK Germany

nwg

RTECS 

DG2736000

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Nafamo­stat mesy­late CAS 82956-11-4

Iden­ti­fi­ca­tion Methods

HPLC

Puri­ty

99% min

Shelf Life

2 years

Stor­age

Under room tem­per­a­ture away from light

Known Appli­ca­tion

Often used as a pro­tease inhibitor. Can strong­ly inhib­it mem­brane pro­teas­es, der­mal release enzymes, plas­min, fib­rin and the clas­si­cal path­ways Clr-, Cls- and oth­er trypsin-like seri­nase pro­teas­es. Chem­i­cal­book white-bound trypsin has the same inhibito­ry effect as free trypsin. It is used to improve acute con­di­tions such as acute pan­cre­ati­tis, acute exac­er­ba­tion of chron­ic pan­cre­ati­tis, post­op­er­a­tive acute pan­cre­ati­tis, acute pan­cre­ati­tis after pan­cre­atog­ra­phy, and trau­mat­ic pan­cre­ati­tis. Recent stud­ies have shown good ther­a­peu­tic effects on new coronaviruses.

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​n​a​f​a​m​o​s​t​a​t​-​m​e​s​y​l​a​t​e​-​c​a​s​-​8​2​9​5​6​-​1​1​-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the House.